Page 27 - Read Online
P. 27

Chakraborty et al. Extracell Vesicles Circ Nucleic Acids 2023;4:27-43  Extracellular Vesicles and
               DOI: 10.20517/evcna.2023.05
                                                                        Circulating Nucleic Acids




               Review                                                                        Open Access



               Hijacking intercellular trafficking for the spread of
               protein aggregates in neurodegenerative diseases: a

               focus on tunneling nanotubes (TNTs)


               Ranabir Chakraborty 1,2,# , Sevan Belian 1,2,# , Chiara Zurzolo 1,3
               1
                Institut Pasteur, Université Paris Cité, CNRS UMR 3691, Membrane Traffic and Pathogenesis, Paris F-75015, France.
               2
                Université Paris Saclay, Gif-sur-Yvette, Paris 91190, France.
               3
                Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
               #
                Authors contributed equally.
               Correspondence to: Chiara Zurzolo, M.D., PhD., Biologie cellulaire et infection, Institut Pasteur, Université Paris Cité, 25-28 Rue
               du Docteur Roux Institut Pasteur, Paris F-75015, France. E-mail: chiara.zurzolo@pasteur.fr
               How to cite this article: Chakraborty R, Belian S, Zurzolo C. Hijacking intercellular trafficking for the spread of protein aggregates
               in neurodegenerative diseases: a focus on tunneling nanotubes (TNTs). Extracell Vesicles Circ Nucleic Acids 2023;4:27-43.
               https://dx.doi.org/10.20517/evcna.2023.05

               Received: 16 Jan 2023  First Decision: 16 Feb 2023  Revised: 24 Feb 2023  Accepted: 3 Mar 2023  Published: 9 Mar 2023

               Academic Editors: Yoke Peng Loh  Copy Editor: Ying Han  Production Editor: Ying Han

               Abstract
               Over the years, the influence of secretory mechanisms on intercellular communication has been extensively
               studied. In the central nervous system (CNS), both trans-synaptic (neurotransmitter-based) and long-distance
               (extracellular vesicles-based) communications regulate activities and homeostasis. In less than a couple of
               decades, however, there has been a major paradigm shift in our understanding of intercellular communication.
               Increasing evidence suggests that besides secretory mechanisms (via extracellular vesicles), several cells are
               capable of establishing long-distance communication routes referred to as Tunneling Nanotubes (TNTs). TNTs are
               membranous bridges classically supported by F-Actin filaments, allowing for the exchange of different types of
               intracellular components between the connected cells, ranging from ions and organelles to pathogens and toxic
               protein aggregates. The roles of TNTs in pathological spreading of several neurodegenerative conditions such as
               Prion diseases, Alzheimer’s disease (AD), Parkinson’s disease (PD), and Huntington’s disease (HD) have been well
               established. However, the fragile nature of these structures and lack of specific biomarkers raised some skepticism
               regarding  their  existence.  In  this  review,  we  will  first  place  TNTs  within  the  spectrum  of  intercellular
               communication mechanisms before discussing their known and hypothesized biological relevance in vitro and in
               vivo in physiological and neurodegenerative contexts. Finally, we discuss the challenges and promising prospects in
               the field of TNT studies.




                           © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                              www.evcna.com
   22   23   24   25   26   27   28   29   30   31   32